Puma Biotechnology Inc. (NYSE:PBYI)

CAPS Rating: 1 out of 5

Results 1 - 4 of 4

Recs

0
Member Avatar usubanas (99.67) Submitted: 7/24/2014 1:36:32 AM : Underperform Start Price: $226.00 PBYI Score: -7.87

7B already. I don't see any company paying more than that.

Recs

0
Member Avatar CramersSkeeDaddy (98.24) Submitted: 7/23/2014 2:04:00 PM : Underperform Start Price: $232.10 PBYI Score: -4.99

up 300% in one day, enough said. Hopefully they do cure/treat all cancer but the short squeeze will likely end soon. No or little revenue, or earnings.

Recs

0
Member Avatar dabhsar (< 20) Submitted: 6/2/2013 8:56:29 AM : Outperform Start Price: $39.55 PBYI Score: +489.58

This small Bio Tech company is onto key medicine break through.

Recs

0
Member Avatar IBDContrarian (22.32) Submitted: 4/6/2013 1:50:39 PM : Underperform Start Price: $30.95 PBYI Score: -652.33

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MEDICAL 1 96 -- A- NO EARN

Results 1 - 4 of 4

Featured Broker Partners


Advertisement